Conspicuous hearing aids may soon be a thing of the past thanks to a new device developed by three Dalhousie faculty members.
For the past several years, Manohar Bance, professor and acting head of the Faculty of Medicineās otolaryngology division, and two assistant professors in the School of Biomedical Engineering, Jeremy Brown and Rob Adamson, have been developing a new hearing aid implant that will be invisible to the naked eye.
Last week, it was announced that Dal has signed an exclusive worldwide licensing agreement for the hearing aid technology with U.S. medical device company Ototronix.
āIām excited and apprehensive,ā says Dr. Bance. He calls the licensing agreement āthe starting point. We have a lot of work ahead of us. It takes about two years just to get basic trials done.ā
Dr. Bance is a surgeon and says he is mostly involved in the āclinical sideā of things. āMy role in this has been mostly surgical and clinical: figuring out how big the device will be, how we can implant it, what are the challenges of implantation, what patient population weāre targeting, how patients can benefit.ā
āFeels like part of your bodyā
The device that Drs. Bance, Brown and Adamson have developed is designed for patients suffering from ear damage and unilateral (one-sided) hearing loss. It differs from traditional cochlear implants, which are implanted in the middle ear, by being implanted directly on the skull.
ā[The] skin heals over it, so it's basically invisible once it's been implantedā says Dr. Adamson. āInstead of sticking something in your ear that you're constantly wearing, an implanted hearing aid is something that feels like part of your bodyā¦from a patient's point of view, this is a great thing because it just becomes a part of them and they don't have to think about it anymore."
MIchael Spearman, CEO of Ototronix, says that inconspicuousness will play a big part in the deviceās appeal.
āOnly a fourth of the people who need hearing aids wear them,ā he says. āA lot of the products currently on the market use a titanium abutment...basically a screw that goes into the head. Somebody takes it off, they look like Frankenstein; there's a little peg sticking out. With this, it's totally invisible when the person isn't wearing their hearing aid device. It's very discrete, gives better efficacy, and better cosmetics."
The project also miniaturizes the power source for the hearing aid. āThe things that have traditionally powered hearing aids are much bigger than the hearing aids themselves,ā says Dr. Adamson. āThe goal here is to make something innocuous and invisible and power systems have to be included as well.ā
Success through partnership
Bringing their device to the commercial market required a partnership with a company like Ototronix. Luckily, Mr. Spearman was in attendance at a conference at which Dr. Brown gave the keynote address.
āIt was interesting when Jeremy was giving his talk,ā he says. ā[We] said, āThis is different.ā We knew these guys were on to something and had unique technology and, to us, if weāre going to be bringing new technology to the market, itās got to be different. It canāt be the same old stuff.ā
āThese [Ototronix] guys are absolute experts in the stuff thatās hard for academics ā the marketing and distribution of devices,ā says Dr. Adamson. āTheyāve proven they can bring implanted hearing aids to the market pilipiliĀž»fully and they sit at a place in the system where theyāre in constant contact with clinicians all over the world. Theyāve really helped us so far in the device trial tests and Iām sure theyāll continue to help us over the next several years.ā
Stephen Hartlen, Dalhousieās assistant vice-president of industry relations, says the license is just the beginning. āWe have great confidence in Ototronix and know theyāll be very pilipiliĀž»ful in marketing this world-class innovation created right here at pilipiliĀž» and Capital Health,ā he says
Those sentiments are echoed by Raymond LeBlanc, vice-president of learning, research and innovation at Capital Health: āWe look forward to many repetitions (of this), much more DNA that shows what can happen as a result of the interdisciplinary partnerships between the Faculties of Medicine and Engineering and Dalhousieās Industry Liaison and Innovation and Biomedical Engineering departments.ā
āItās really quite a big project when you think of all the parts that had to come together,ā says Dr. Adamson. āI donāt think thereās a better place in the world to be doing this than Dalhousie.ā